Evidence map›Paper›PMID 41912170›Full record

ArticleDermatology practical & conceptual2026

Prospective Lesion-Level Analysis of the Inverse Approach for Lentigo Maligna in Real-World Clinical Practice.

Ece Gökyayla, Aylin Türel Ermertcan, Peyker Temiz

Abstract read
In one paragraph

Article in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ece GökyaylaDepartment of Dermatology and Venereology, Uşak Research and Training Hospital, Uşak, Turkey.
Aylin Türel ErmertcanDepartment of Dermatology and Venereology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
Peyker TemizDepartment of Pathology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLentigo maligna (LM) is a melanoma subtype that develops predominantly on photodamaged skin. Classic criteria may miss early lesions due to subtle or partially present malignancy-associated features or their overlap with benign or premalignant conditions related to photodamage. The recently introduced inverse approach, which focuses on the absence of typical non-melanoma dermoscopic features, has shown promise in identifying these challenging cases.

objectivesThis study prospectively evaluated the real-life performance of the inverse approach for differentiating LM from its mimickers and assessed its ability to detect lesions lacking classic criteria.

methodsThis prospective study enrolled consecutive patients presenting with pigmented flat lesion(s) on the head and neck region. Each lesion was photographed and independently assessed by two dermatologists using classic and inverse approach criteria. Lesions showing at least one classic LM criterion or that did not predominantly (≥50% of the surface area) display any inverse approach feature were considered suspicious for LM and underwent biopsy for histopathological evaluation.

resultsA total of 956 lesions from 68 patients were initially evaluated. Of these, 795 (83.2%) were diagnosed as solar lentigo or flat seborrheic keratosis and 145 (15.2%) as actinic keratosis. Classic criteria for lentigo maligna identified four lesions as suspicious, all of which were histopathologically confirmed; three additional lesions were suspicious only by the inverse approach and were likewise confirmed as LM.

conclusionsIn this real-life cohort, the inverse approach identified all observed LM cases, including those lacking classic criteria or showing only subtle classic criteria; this approach may serve as a practical adjunct for evaluating pigmented facial lesions. Larger multicenter studies with systematic verification are needed for broader validation.

Identifiers

PMID41912170
PMCPMC12952810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.